肺癌患者骨与关节18F-FAPI摄取增高的特征与分布
骨转移SUVmax显著高于良性病灶,但两者重叠,不能仅凭SUVmax鉴别;FAPI对颅骨转移的识别优于FDG。
要点
- 骨转移主要位于椎体、骨盆和肋骨,良性病变多见于椎体边缘、牙槽骨和肩关节。
- 骨转移SUVmax显著高于良性病变,但无法准确区分良恶性。
- FAPI对颅骨转移的识别优于FDG,TBRmet/brain更高。
核心结论
- 18F-FAPI PET/CT是检测肺癌患者骨与关节病变的有价值手段
- 恶性病变SUVmax高于良性病变,但不能准确鉴别良恶性
- 不同病理类型肺癌的FAPI摄取存在差异
研究设计与样本
- 记录并分析骨与关节摄取增高的病灶分布及SUVmax
- 比较骨转移灶在18F-FDG与18F-FAPI-04 PET/CT的SUVmax
关键影像表现/征象
- 53例患者共262个病灶出现18F-FAPI摄取
- 骨转移主要位于椎体、骨盆和肋骨
- 良性病变主要位于椎体边缘、牙槽骨和肩关节
诊断标准与关键数值
- 骨转移SUVmax显著高于良性病变(具体数值原文以公式表示,未提供)
- 关节炎和牙周炎SUVmax高于退行性病变(关节炎、牙周炎、退行性病变的具体SUVmax及P值原文以公式表示)
- 骨转移灶SUVmax在18F-FDG与18F-FAPI PET/CT间相当
临床应用与阅片要点
- 阅片时注意骨转移好发部位(椎体、骨盆、肋骨)与良性病变好发部位(椎体边缘、牙槽骨、肩关节)的分布差异
- 不应仅凭SUVmax鉴别骨与关节病变的良恶性
- 对于肺癌患者,FAPI可用于评估颅骨转移
- 需结合病理类型(NSCLC vs SCLC)考虑FAPI摄取差异
局限性
- 回顾性研究设计
- 单中心研究
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study investigated the distribution and characteristics of various bone and joint lesions on 18F-FAPI PET/CT in lung cancer patients.
METHODS: Seventy-four lung cancer patients who underwent 18F-FAPI PET/CT were reviewed. Bone and joint lesions with elevated 18F-FAPI uptake were recorded and analyzed. The distribution and maximum uptake value (SUVmax) of different benign lesions or bone metastases were presented. In addition, the SUVmax of bone metastases on 18F-FDG and 18F-FAPI-04 PET/CT were also compared.
RESULTS: In 53 patients, a total of 262 lesions presented 18F-FAPI accumulation. Bone metastases were mainly in vertebrae, pelvis, and ribs, while benign lesions were in vertebral margins, alveolar bone, and shoulder joints. The SUVmax of bone metastases was significantly higher than that of benign lesions ([Formula: see text] vs. [Formula: see text], [Formula: see text]), with NSCLC cases having higher SUVmax values than SCLC cases ([Formula: see text] vs. [Formula: see text], [Formula: see text]). Among benign lesions, arthritis and periodontitis demonstrated higher SUVmax than degenerative lesions (arthritis: [Formula: see text]; periodontitis: [Formula: see text]; degenerative diseases: [Formula: see text]; [Formula: see text] and [Formula: see text], respectively). The SUVmax of bone metastases was comparable between 18F-FDG and 18F-FAPI PET/CT. However, 18F-FAPI PET/CT was found to be superior in identifying cranial metastases compared to 18F-FDG PET/CT (TBRmet/brain: [Formula: see text] vs. [Formula: see text], [Formula: see text]).
CONCLUSION: This study demonstrated that 18F-FAPI PET/CT is a valuable imaging modality for detecting bone and joint lesions in lung cancer patients. The SUVmax of malignant lesions was higher than that of benign lesions, but cannot accurately distinguish benign and malignant lesions. The uptake of FAPI differs among lesions with different pathological types.
引用
- Liu, Yan, Qin, et al. Increased 18F-FAPI uptake in bones and joints of lung cancer patients: characteristics and distributions. Skeletal Radiol. 2023. PMID: 37129613. doi:10.1007/s00256-023-04335-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。